SCHEMBL31346451

SCHEMBL31346451

CCOC(=O)C(C)(CF)S(C)(=O)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.37
CYP4A11 Q02928 3/20 0.37
PKM P14618 3/20 0.35
MMP8 P22894 1/20 0.35
ALDH1A1 P00352 3/20 0.34
TRPA1 O75762 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 2/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
RECQL P46063 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ABCB11 O95342 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
HTR2A P28223 1/20 0.33
PMP22 Q01453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28072693 0.84 CYP4F2 (0.39) CYP4F2CYP4A11PKMMMP8ALDH1A1
SCHEMBL31346400 0.80 DGAT1 (0.34)
SCHEMBL2015355 0.79 CYP4F2 (0.40) CYP4F2CYP4A11PKMMMP8ALDH1A1
SCHEMBL2018121 0.79 CYP4F2 (0.40) CYP4F2CYP4A11PKMMMP8ALDH1A1
SCHEMBL22446274 0.78 PKM (0.39) CYP4F2CYP4A11PKMMMP8KDM4E
SCHEMBL18978425 0.78 PKM (0.39) CYP4F2CYP4A11PKMMMP8KDM4E
SCHEMBL17202214 0.77 PKM (0.36) CYP4F2CYP4A11PKMMMP8ALDH1A1
SCHEMBL17213256 0.77 PKM (0.36) CYP4F2CYP4A11PKMMMP8ALDH1A1
Hydrochloric Acid SCHEMBL28224630 0.77 PKM (0.38) CYP4F2CYP4A11PKMMMP8KDM4E
Hydrochloric Acid SCHEMBL18954073 0.77 PKM (0.38) CYP4F2CYP4A11PKMMMP8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747258-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics, Inc. (US) 2026-05-27 EP disclosed
WO-2025024329-A2 COMPOUNDS, COMPOSITIONS, AND METHODS NICO THERAPEUTICS, INC. (US) 2025-01-30 WO disclosed